Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'— Key Learning Points for Surgeons. Issue 1 (July 2015) - Hurst, K.V.; Lee, R.; Milosevic, I.; Handa, A.